6-K
File 001-15170
GSK ANNOUNCES FDA MEETING OUTCOME ON DAPRODUSTAT
- Filing date
- 27 Oct 2022
- Reporting date
- 27 Oct 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
GSK plc reports
- Company location
- London
GSK plc has filed 6,818 SEC EDGAR filings since 12 Jan 2001
SEC filing history
Showing 926-950 of 1,000 matching filings.
Per page
25
Current page
38
6-K
File 001-15170
CONTRAST PHASE III PROGRAMME FOR OTILIMAB UPDATE
- Filing date
- 27 Oct 2022
- Reporting date
- 27 Oct 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
BOARD COMMITTEE CHANGES
- Filing date
- 25 Oct 2022
- Reporting date
- 25 Oct 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
RSV OLDER ADULT VACCINE SUBMISSION IN JAPAN
- Filing date
- 21 Oct 2022
- Reporting date
- 21 Oct 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
MENVEO NEW SINGLE-VIAL APPROVED BY US FDA
- Filing date
- 17 Oct 2022
- Reporting date
- 17 Oct 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 14 Oct 2022
- Reporting date
- 14 Oct 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 13 Oct 2022
- Reporting date
- 13 Oct 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 13 Oct 2022
- Reporting date
- 13 Oct 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 13 Oct 2022
- Reporting date
- 13 Oct 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
EFFICACY RESULTS FOR GSK'S OLDER ADULT RSV VACCINE
- Filing date
- 13 Oct 2022
- Reporting date
- 13 Oct 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 12 Oct 2022
- Reporting date
- 12 Oct 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
US FDA APPROVES BOOSTRIX MATERNAL IMMUNISATION
- Filing date
- 11 Oct 2022
- Reporting date
- 11 Oct 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 07 Oct 2022
- Reporting date
- 07 Oct 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 07 Oct 2022
- Reporting date
- 07 Oct 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TOTAL VOTING RIGHTS
- Filing date
- 03 Oct 2022
- Reporting date
- 03 Oct 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 30 Sep 2022
- Reporting date
- 30 Sep 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 26 Sep 2022
- Reporting date
- 26 Sep 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK CHIEF FINANCIAL OFFICER SUCCESSION
- Filing date
- 26 Sep 2022
- Reporting date
- 26 Sep 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
US FDA ODAC REVIEW OF ZEJULA PHASE III NOVA TRIAL
- Filing date
- 22 Sep 2022
- Reporting date
- 22 Sep 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK AND SPERO THERAPEUTICS LICENCE FOR TEBIPENEM
- Filing date
- 22 Sep 2022
- Reporting date
- 22 Sep 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 21 Sep 2022
- Reporting date
- 21 Sep 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
File 001-36033
4 filing
- Filing date
- 20 Sep 2022
- Reporting date
- 16 Sep 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13D/A
AMENDMENT TO FORM SC 13D
- Filing date
- 20 Sep 2022
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
25-NSE
File 001-15170
25-NSE filing
- Filing date
- 15 Sep 2022
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 13 Sep 2022
- Reporting date
- 13 Sep 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing